small molecule

EMROSI

MINOCYCLINE HYDROCHLORIDE

Loss of exclusivityJanuary 2039latest FDA-listed patent expiry

CompanyJOURNEY MEDICAL CORP

Drug detail

Brand name	EMROSI
Active ingredient	MINOCYCLINE HYDROCHLORIDE
Strength	EQ 40MG BASE
Dosage form	CAPSULE, EXTENDED RELEASE
Route	ORAL
Modality	Small molecule
FDA approval	November 2024
Marketing status	RX

Listed patents

Patent	Expires	Type
11364212	January 2039	use U-4043
11191740	January 2039	use U-4043
10905664	January 2039	use U-4043
12594252	January 2039	use U-4043

Regulatory exclusivity

Code	Expires
NP	November 2027

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from JOURNEY MEDICAL CORP